Found 10 results
Filters: Keyword is Survival Rate  [Clear All Filters]
2018
Mateos M-V, Dimopoulos MA, Cavo M, Suzuki K, Jakubowiak A, Knop S, Doyen C, Lucio P, Nagy Z, Kaplan P et al..  2018.  Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma.. N Engl J Med. 378(6):518-528.
Goncalves MD, Taylor S, Halpenny DF, Schwitzer E, Gandelman S, Jackson J, Lukose A, Plodkowski AJ, Tan KS, Dunphy M et al..  2018.  Imaging skeletal muscle volume, density, and FDG uptake before and after induction therapy for non-small cell lung cancer.. Clin Radiol. 73(5):505.e1-505.e8.
2017
Becattini S, Littmann ER, Carter RA, Kim SG, Morjaria SM, Ling L, Gyaltshen Y, Fontana E, Taur Y, Leiner IM et al..  2017.  Commensal microbes provide first line defense against infection.. J Exp Med. 214(7):1973-1989.
Brose MS, Worden FP, Newbold KL, Guo M, Hurria A.  2017.  Effect of Age on the Efficacy and Safety of Lenvatinib in Radioiodine-Refractory Differentiated Thyroid Cancer in the Phase III SELECT Trial.. J Clin Oncol. 35(23):2692-2699.
Shackford SR, Dunne CE, Karmy-Jones R, Long W, Teso D, Schreiber MA, Watson J, Watson C, McIntyre RC, Ferrigno L et al..  2017.  The evolution of care improves outcome in blunt thoracic aortic injury: A Western Trauma Association multicenter study.. J Trauma Acute Care Surg. 83(6):1006-1013.
2016
Liang LW, Perez AR, Cangemi NA, Zhou Q, Iasonos A, Abu-Rustum N, Alektiar KM, Makker V.  2016.  An Assessment of Prognostic Factors, Adjuvant Treatment, and Outcomes of Stage IA Polyp-Limited Versus Endometrium-Limited Type II Endometrial Carcinoma.. Int J Gynecol Cancer. 26(3):497-504.
Weber B, Bersch-Ferreira ÂCristine, Torreglosa CRagne, Ross-Fernandes MBeatriz, da Silva JTereza, Galante APolo, Lara Ede Sousa, Costa RPerim, Soares RMarques, Cavalcanti ABiasi et al..  2016.  The Brazilian Cardioprotective Nutritional Program to reduce events and risk factors in secondary prevention for cardiovascular disease: study protocol (The BALANCE Program Trial).. Am Heart J. 171(1):73-81.e1-2.
2014
Barringhaus KG, Akhter M, Rade JJ, Smith C, Fisher DZ.  2014.  Operator and institutional experience reduces room-to-balloon times for transradial primary percutaneous coronary intervention.. J Invasive Cardiol. 26(2):80-6.
2013
Brunner AM, Sadrzadeh H, Feng Y, Drapkin BJ, Ballen KK, Attar EC, Amrein PC, McAfee SL, Bin Chen Y-, Neuberg DS et al..  2013.  Association between baseline body mass index and overall survival among patients over age 60 with acute myeloid leukemia.. Am J Hematol. 88(8):642-6.
2007
Bruna A, Darken RS, Rojo F, Ocaña A, Peñuelas S, Arias A, Paris R, Tortosa A, Mora J, Baselga J et al..  2007.  High TGFbeta-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene.. Cancer Cell. 11(2):147-60.